Products developed by Theratechnologies target unmet medical needs in commercially attractive specialty markets.

Investors

Latest news

  • March 1, 2010

    Theratechnologies Announces Publication of Second Phase 3 Results in JAIDS More...

  • February 25, 2010

    Theratechnologies announces a tentative new date for the FDA Advisory Committee review of the tesamorelin New Drug Application More...

Events

  • March 25, 2010

    Annual Meeting of Shareholders, Montréal, Canada

    Thursday, March 25, 2010, at 10:00 a.m.
    Centre Mont-Royal
    2200 Mansfield
    Montréal, Quebec More...

 

Stock information

Symbol TSX : TH
Last trade 5.39
Open 5.00
Net change +0.40
High 5.42
Low 5.00
Volume 291,322
As of 2010-03-09
15:59 EST
Note: Quotes are delayed.
For informational purposes only.